MRC1 and cancer: IMPLICATIONS FOR PATIENT CARE: Further development of [68Ga]Ga-NOTA-anti-CD206-sdAb could enable the quantification of CD206-expressing macrophages in the tumor microenvironment and could help to reveal the role of these cells in local immune-related resistance mechanisms to cancer treatments.